hepatic artery embolization
Sponsors
University Hospital Birmingham, Delcath Systems Inc., Roswell Park Cancer Institute, Rutgers, The State University of New Jersey, Abramson Cancer Center at Penn Medicine
Conditions
Adult Primary Hepatocellular CarcinomaAdvanced Adult Primary Liver CancerBreast CancerColorectal CancerGastric CancerHepatocellular CarcinomaIntraocular MelanomaLiver Cancer
Early Phase 1
Phase 1
Cyclophosphamide, Radiation Therapy, and Poly ICLC in Treating Patients With Unresectable, Recurrent, Primary, or Metastatic Liver Cancer
NCT00553683
Start: 2007-10-31End: 2014-07-31Target: 50Updated: 2014-01-14
Sorafenib Tosylate and Chemoembolization in Treating Patients With Unresectable Liver Cancer
CompletedNCT01042041
Start: 2009-09-30End: 2010-12-31Target: 18Updated: 2013-02-26
Chemoembolization Using Irinotecan in Treating Patients With Liver Metastases From Metastatic Colon or Rectal Cancer
TerminatedNCT01285102
Start: 2010-10-31End: 2013-01-31Updated: 2021-12-20
Irinotecan-Eluting Beads in Treating Patients With Refractory Metastatic Colon or Rectal Cancer That Has Spread to the Liver
TerminatedNCT02110953
Start: 2016-01-29End: 2017-08-16Updated: 2018-02-26
Phase 2
Phase 3
Doxorubicin By Infusion or Chemoembolization in Treating Patients With Advanced Unresectable Hepatocellular Carcinoma (Liver Cancer)
NCT00079027
Start: 2004-04-30Target: 280Updated: 2013-12-18
Hepatic Arterial Infusion With Melphalan Compared With Standard Therapy in Treating Patients With Unresectable Liver Metastases Due to Melanoma
CompletedNCT00324727
Start: 2006-02-28End: 2012-08-31Updated: 2021-06-21